PhysiciansÕ approach to the diagnosis and treatment of tuberculosis in Afyon, Turkey
MATERIAL AND METHODS: A questionnaire on tuberculosis was filled out by 208 physicians (46 specialists and 162 general practitioners).
RESULTS: Bacteriology was the preferred method of diagnosis among 75% (n = 156) of the physicians. For treatment of newly diagnosed tuberculosis, 64.4% prescribed a three-drug and 30.8% a four-drug combination. The combination most often selected was HRE (36.5%). Preferred treatment durations were 9 (38.5%) and 6 (34.6%) months. For patients with treatment failure, 20.2% of the physicians would add a new drug to the existing regimen, while 65.4% would refer the patient to a specialised tuberculosis unit. For the treatment of childhood tuberculosis, 38.5% of the physicians thought a two-drug treatment was adequate. For tuberculosis during pregnancy, 9.7% of the physicians offered treatment after the pregnancy, while 11.5% offered treatment after abortion.
CONCLUSION: The knowledge of the physicians about the diagnosis and treatment of tuberculosis was deemed insufficient. Additional educational resources for physicians may contribute to improvements in tuberculosis control.
Document Type: Regular Paper
Affiliations: Department of Chest Diseases and Tuberculosis, Afyon Kocatepe University Medical School, Afyon, Turkey
Publication date: 2003-03-01
The International Journal of Tuberculosis and Lung Disease publishes articles on all aspects of lung health, including public health-related issues such as training programmes, cost-benefit analysis, legislation, epidemiology, intervention studies and health systems research. The IJTLD is dedicated to the continuing education of physicians and health personnel and the dissemination of information on tuberculosis and lung health world-wide.
Certain IJTLD articles are selected for translation into French, Spanish, Chinese or Russian. They are available on the Union website
- Editorial Board
- Information for Authors
- Subscribe to this Title
- International Journal of Tuberculosis and Lung Disease
- Public Health Action
- Ingenta Connect is not responsible for the content or availability of external websites